{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:38:44Z","timestamp":1790429924986,"version":"4.1.0"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T00:00:00Z","timestamp":1551225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI012\/02025"],"award-info":[{"award-number":["PI012\/02025"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fundacion ERESA"},{"name":"Donation of AFECANCER"},{"name":"Fundacio per al Foment de la Investigacio Sanitaria i Biomedica de la Comunitat Valenciana","award":["UGP-15-237"],"award-info":[{"award-number":["UGP-15-237"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0212581","type":"journal-article","created":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T19:07:35Z","timestamp":1551294455000},"page":"e0212581","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":44,"title":["Radiotherapy resistance acquisition in Glioblastoma. Role of SOCS1 and SOCS3"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1979-0949","authenticated-orcid":true,"given":"Maria Paz","family":"Ventero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Fuentes-Baile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Quereda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Perez-Valeciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Alenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Garcia-Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Dorado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4012-6973","authenticated-orcid":true,"given":"Victor","family":"Manuel Barbera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1564-3602","authenticated-orcid":true,"given":"Miguel","family":"Saceda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,2,27]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/now207","article-title":"CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009\u20132013","volume":"18","author":"QT Ostrom","year":"2016","journal-title":"Neuro Oncol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00401-005-0991-y","article-title":"Epidemiology and etiology of gliomas","volume":"109","author":"H Ohgaki","year":"2005","journal-title":"Acta Neuropathol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1158\/1078-0432.CCR-12-3002","article-title":"The Definition of Primary and Secondary Glioblastoma","volume":"19","author":"H Ohgaki","year":"2013","journal-title":"Clin Cancer Res"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","article-title":"The 2007 WHO Classification of Tumours of the Central Nervous System","volume":"114","author":"DN Louis","year":"2007","journal-title":"Acta Neuropathol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary","author":"DN Louis","year":"2016","journal-title":"Acta Neuropathol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.15252\/emmm.201302627","article-title":"Emerging treatment strategies for glioblastoma multiforme","volume":"6","author":"SK Carlsson","year":"2014","journal-title":"EMBO Mol Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma","volume":"352","author":"R Stupp","year":"2005","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/ana.22425","article-title":"Current concepts and management of glioblastoma","volume":"70","author":"M Preusser","year":"2011","journal-title":"Ann Neurol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1200\/JCO.2005.04.5963","article-title":"Radiotherapy and Temozolomide for Newly Diagnosed Glioblastoma: Recursive Partitioning Analysis of the EORTC 26981\/22981-NCIC CE3 Phase III Randomized Trial","volume":"24","author":"R-O Mirimanoff","year":"2006","journal-title":"J Clin Oncol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/ncponc1155","article-title":"Mechanisms of Disease: temozolomide and glioblastoma\u2014look to the future","volume":"5","author":"MM Mrugala","year":"2008","journal-title":"Nat Clin Pract Oncol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1007\/s10147-014-0769-0","article-title":"A Phase III study of radiation therapy (RT) and O6-benzylguanine + BCNU versus RT and BCNU alone and methylation status in newly diagnosed glioblastoma and gliosarcoma: Southwest Oncology Group (SWOG) study S0001","volume":"20","author":"DT Blumenthal","year":"2015","journal-title":"Int J Clin Oncol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"e0140131","DOI":"10.1371\/journal.pone.0140131","article-title":"Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression","volume":"10","author":"G Perazzoli","year":"2015","journal-title":"PLoS One"},{"key":"ref13","first-page":"1","article-title":"SOCS proteins in development and disease","volume":"2","author":"MC Trengove","year":"2013","journal-title":"Am J Clin Exp Immunol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1242\/jcs.00963","article-title":"The JAK\/STAT signaling pathway","volume":"117","author":"JS Rawlings","year":"2004","journal-title":"J Cell Sci"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/bjc.2015.233","article-title":"The role of JAK\/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours","volume":"113","author":"SJ Thomas","year":"2015","journal-title":"Br J Cancer"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"630797","DOI":"10.1155\/2014\/630797","article-title":"The role of suppressors of cytokine signalling in human neoplasms","volume":"2014","author":"W Sasi","year":"2014","journal-title":"Mol Biol Int"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1002\/ijc.23805","article-title":"Prognostic relevance of SOCS3 hypermethylation in patients with glioblastoma multiforme","volume":"123","author":"M Martini","year":"2008","journal-title":"Int J Cancer"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1158\/1078-0432.CCR-06-2303","article-title":"Reciprocal Regulation of SOCS 1 and SOCS3 Enhances Resistance to Ionizing Radiation in Glioblastoma Multiforme","volume":"13","author":"H Zhou","year":"2007","journal-title":"Clin Cancer Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00432-014-1838-5","article-title":"Low expression of SOCS-1 and SOCS-3 is a poor prognostic indicator for gastric cancer patients","volume":"141","author":"G Li","year":"2015","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e0123133","DOI":"10.1371\/journal.pone.0123133","article-title":"Suppressor of Cytokine Signaling (SOCS) Genes Are Silenced by DNA Hypermethylation and Histone Deacetylation and Regulate Response to Radiotherapy in Cervical Cancer Cells","volume":"10","author":"M-H Kim","year":"2015","journal-title":"PLoS One"},{"key":"ref21","doi-asserted-by":"crossref","DOI":"10.2174\/0929867325666181016163110","article-title":"Recent Progress in Histone Deacetylase Inhibitors as Anticancer Agents","volume":"25","author":"L Cappellacci","year":"2018","journal-title":"Curr Med Chem"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13045-018-0576-6","article-title":"The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma","volume":"11","author":"C Festuccia","year":"2018","journal-title":"J Hematol Oncol"},{"key":"ref23","article-title":"Histone deacetylase inhibitors sensitize 5\u2011fluorouracil\u2011resistant MDA\u2011MB\u2011468 breast cancer cells to 5\u2011fluorouracil","author":"T Minegaki","year":"2018","journal-title":"Oncol Lett"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"56210","DOI":"10.18632\/oncotarget.14813","article-title":"Time dependent modulation of tumor radiosensitivity by a pan HDAC inhibitor: abexinostat","volume":"8","author":"S Rivera","year":"2017","journal-title":"Oncotarget"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/mc.20777","article-title":"Trichostatin A, a histone deacetylase inhibitor, suppresses JAK2\/STAT3 signaling via inducing the promoter-associated histone acetylation of SOCS1 and SOCS3 in human colorectal cancer cells","volume":"51","author":"H Xiong","year":"2012","journal-title":"Mol Carcinog"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3390\/cells7090131","article-title":"PDGFR and IGF-1R Inhibitors Induce a G2\/M Arrest and Subsequent Cell Death in Human Glioblastoma Cell Lines","volume":"7","author":"E Carrasco-Garcia","year":"2018","journal-title":"Cells"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1158\/1078-0432.CCR-09-2902","article-title":"IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group","volume":"16","author":"MJ van den Bent","year":"2010","journal-title":"Clin Cancer Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"12428","DOI":"10.18632\/oncotarget.2660","article-title":"TERT promoter mutations are associated with distant metastases in upper tract urothelial carcinomas and serve as urinary biomarkers detected by a sensitive castPCR","volume":"5","author":"K Wang","year":"2014","journal-title":"Oncotarget"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/labinvest.3700664","article-title":"MS-MLPA: an attractive alternative laboratory assay for robust, reliable and semiquantitative detection of MGMT promoter hypermethylation in gliomas","volume":"87","author":"JWM Jeuken","year":"2007","journal-title":"Lab Investig"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative CT method","volume":"3","author":"TD Schmittgen","year":"2008","journal-title":"Nat Protoc"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4103\/0976-3147.168426","article-title":"Immunohistochemical expression of glial fibrillary acidic protein and CAM5.2 in glial tumors and their role in differentiating glial tumors from metastatic tumors of central nervous system","volume":"6","author":"R Goyal","year":"2015","journal-title":"J Neurosci Rural Pract"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJMoa0808710","article-title":"IDH1 and IDH2 mutations in gliomas","volume":"360","author":"H Yan","year":"2009","journal-title":"N Engl J Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.arcmed.2013.04.004","article-title":"MGMT Promoter Methylation and Glioblastoma Prognosis: A Systematic Review and Meta-analysis","volume":"44","author":"Y Chen","year":"2013","journal-title":"Arch Med Res"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1476-4598-10-128","article-title":"Chemoresistance of glioblastoma cancer stem cells\u2014much more complex than expected","volume":"10","author":"D Beier","year":"2011","journal-title":"Mol Cancer"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1476-4598-5-67","article-title":"Analysis of gene expression and chemoresistance of CD133 + cancer stem cells in glioblastoma","volume":"5","author":"G Liu","year":"2006","journal-title":"Mol Cancer"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2741\/S372","article-title":"Suppressors of cytokine signalling-3 and -1 in human carcinogenesis","volume":"5","author":"Z Culig","year":"2013","journal-title":"Front Biosci (Schol Ed)"},{"issue":"6","key":"ref37","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1158\/1541-7786.MCR-15-0495","article-title":"Signal Transduction SOCS3 Modulates the Response to Enzalutamide and Is Regulated by Androgen Receptor Signaling and CpG Methylation in Prostate Cancer Cells","volume":"14","author":"F Handle","year":"2016","journal-title":"Mol Cancer Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12885-017-3141-8","article-title":"Expression of SOCS1 and the downstream targets of its putative tumor suppressor functions in prostate cancer","volume":"17","author":"M Chevrier","year":"2018","journal-title":"BMC Cancer"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.it.2009.07.001","article-title":"SOCS1 and SOCS3 in the control of CNS immunity","volume":"30","author":"BJ Baker","year":"2009","journal-title":"Trends Immunol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1038\/sj.onc.1209993","article-title":"Expression of SOCS1 and SOCS3 genes is differentially regulated in breast cancer cells in response to proinflammatory cytokine and growth factor signals","volume":"26","author":"MK Evans","year":"2007","journal-title":"Oncogene"},{"key":"ref41","first-page":"719","article-title":"Gene expression changes associated with chemotherapy resistance in Ewing sarcoma cells","volume":"8","author":"L Horbach","year":"2018","journal-title":"Mol Clin Oncol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.exphem.2012.10.012","article-title":"Histone deacetylases inhibitor sodium butyrate inhibits JAK2\/STAT signaling through upregulation of SOCS1 and SOCS3 mediated by HDAC8 inhibition in myeloproliferative neoplasms","volume":"41","author":"S Gao","year":"2013","journal-title":"Exp Hematol"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0215714","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T00:00:00Z","timestamp":1555372800000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0212581","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T19:22:06Z","timestamp":1606591326000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0212581"}},"subtitle":[],"editor":[{"given":"Gabriel F.","family":"Calvo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,2,27]]},"references-count":42,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,2,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0212581","relation":{"correction":[{"id-type":"doi","id":"10.1371\/journal.pone.0215714","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,27]]}}}